These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


129 related items for PubMed ID: 5155896

  • 1. [Immunoreactive insulin, nonesterified fatty acids and glucose in the serum following intravenous administration of glibornuride as compared to tolbutamide].
    Bottermann P, Souvatzoglou A, Schwarz K, Rettig M.
    Verh Dtsch Ges Inn Med; 1971; 77():556-9. PubMed ID: 5155896
    [No Abstract] [Full Text] [Related]

  • 2. [Extrapancreatic effects of sulfonylurea compounds. I. Studies on the effect of tolbutamide and glibornuride on blood sugar, nonesterified fatty acids, glycerin, lactate and pyruvate in the pancreatectomized dog chronically treated with insulin].
    Beyer J, Cordes U, Krall H, Sell G, Schöffling K.
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2167. PubMed ID: 4679246
    [No Abstract] [Full Text] [Related]

  • 3. [Extrapancreatic effects of sulfonylurea compounds. 3. Studies on the additional blood sugar decreasing and antilipolytic effect of tolbutamide, glibornuride, and glibenclamide on completely pancreatectomized dogs, chronically treated with insulin during acute experiment and following pretreatment with sulfonylurea compounds using small doses of sulfonylurea].
    Beyer J, Cordes U, Sell G, Schöffling K.
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2176. PubMed ID: 4198965
    [No Abstract] [Full Text] [Related]

  • 4. [Extrapancreatic effects of sulfonylurea compounds. II. Comparison of equimolar concentrations of tolbutamide, glibornuride, hydroxymethyltolbutamide, carboxytolbutamide, and carboxyglycylamide with reference to their blood-sugar-decreasing and antilipolytic effect on completely pancreatectomized dogs, chronically treated insulin].
    Beyer J, Cordes U, Sell G, Krall H, Schöffling K.
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2172. PubMed ID: 4679247
    [No Abstract] [Full Text] [Related]

  • 5. [Changes in insulin (IRI) and NEFA levels in diabetic subjects after acute intravenous glipizide and tolbutamide administration].
    Fedeli S, Maglia A.
    Arch Sci Med (Torino); 1977 Dec; 134(1):33-8. PubMed ID: 860916
    [Abstract] [Full Text] [Related]

  • 6. [Insulin, glucose and free fatty acids in the serum of healthy and diabetic subjects following solitary oral dose of the sulfonylurea derivative glibornuride].
    Herrlinger H, Dörfler H, Wolfram G, Zöllner N.
    Verh Dtsch Ges Inn Med; 1971 Dec; 77():550-2. PubMed ID: 5155895
    [No Abstract] [Full Text] [Related]

  • 7. [Comparative use of gliquidone and tolbutamide administered intravenously].
    Zilker T, Lüders L, Bottermann P.
    MMW Munch Med Wochenschr; 1975 Sep 05; 117(36):1421-2. PubMed ID: 126376
    [No Abstract] [Full Text] [Related]

  • 8. Circadian variations of carbohydrate tolerance in maturity onset diabetics treated with sulfonylureas.
    Göschke H, Denes A, Girard J, Collard F, Berger W.
    Horm Metab Res; 1974 Sep 05; 6(5):386-91. PubMed ID: 4417576
    [No Abstract] [Full Text] [Related]

  • 9. Response of plasma insulin, serum free fatty acids and blood glucose in growth onset diabetics, to I.V. tolbutamide.
    Kirti S, Dutta PK, Vaishnava H, Singh RB.
    J Assoc Physicians India; 1976 Mar 05; 24(3):141-6. PubMed ID: 1010812
    [No Abstract] [Full Text] [Related]

  • 10. [Levels of basal insulinemia and changes of the plasmatic concentration of nonesterified fatty acids (NEFA) and of blood sugar after administration of tolbutamide in obese children].
    Iafusco F, Pierantoni G, Stoppoloni G, Pacelli V.
    Pediatria (Napoli); 1967 Mar 05; 75(5):780-8. PubMed ID: 5603123
    [No Abstract] [Full Text] [Related]

  • 11. [Comparison of the beta-cytotrophic effect of a new sulfonylurea derivative, glibornuride, and tolbutamide].
    Bottermann P, Souvatzoglou A, Schwarz K, Rettig M.
    Klin Wochenschr; 1971 Jul 01; 49(13):769-70. PubMed ID: 4935073
    [No Abstract] [Full Text] [Related]

  • 12. [Blood sugar, serum insulin, nonesterified fatty acids and somatotropin in daily profile in adult diabetics under monotherapy with various sulfonylureas].
    Happ J, Beyer J, Nest E, Fröhlich A, Althoff PH, Schöffling K.
    Arzneimittelforschung; 1974 Aug 01; 24(8):1228-34. PubMed ID: 4214173
    [No Abstract] [Full Text] [Related]

  • 13. [Behavior of free fatty acids in the serum following tolbutamide administration in normal persons, dietetically regulated and insulin-dependent diabetics of differing body weight and differing initial blood sugar levels].
    Ulrich E, Frank I, Kujat G, Müller G, Seige K.
    Endokrinologie; 1969 Aug 01; 54(5):442-52. PubMed ID: 5359974
    [No Abstract] [Full Text] [Related]

  • 14. Effect of intravenous glibornuride and tolbutamide on myocardial contractility.
    Dubach UC, Burckhardt D, Raeder EA, Forgo I, Amrein R, Bückert A.
    Cardiology; 1979 Aug 01; 64(4):208-14. PubMed ID: 157810
    [Abstract] [Full Text] [Related]

  • 15. [Extrapancreatic effects of sulfonylurea compounds. IV. Increase of the effect of insulin due to tolbutamide, glibornuride, and glibenclamide in vitro].
    Beyer J, Gather W, Schöffling K.
    Arzneimittelforschung; 1972 Dec 01; 22():Suppl 12A:2179. PubMed ID: 4198966
    [No Abstract] [Full Text] [Related]

  • 16. [Metabolic changes induced by intravenous administration of sorbitol to healthy subjects and the effect of tolbutamide and butylbiguanide].
    Brodan V, Kuhn E, Válek J, Slabochová Z, Brodanová M.
    Cas Lek Cesk; 1973 May 04; 112(18):549-55. PubMed ID: 4701731
    [No Abstract] [Full Text] [Related]

  • 17. [The behavior of glucose, pyruvic acid and nonesterified fatty acids following i.v. tolbutamide loading in fatty liver].
    Teichmann W, Bchardt U.
    Dtsch Z Verdau Stoffwechselkr; 1968 May 04; 28(2):217-20. PubMed ID: 5732400
    [No Abstract] [Full Text] [Related]

  • 18. [Mechanism of action of AR 3-ARDF 26, a new betacytotropic sulfonylurea derivative and tolbutamide].
    Zilker T, Bottermann P.
    Verh Dtsch Ges Inn Med; 1972 May 04; 78():1275-8. PubMed ID: 4665516
    [No Abstract] [Full Text] [Related]

  • 19. [Insulin liberation by blood sugar decreasing sulfonamides and by glucose in adult diabetic patients].
    Haupt E, Köberich W, Rosak C, Beyer J, Schöffling K.
    Arzneimittelforschung; 1972 Dec 04; 22():Suppl 12A:2198. PubMed ID: 4198967
    [No Abstract] [Full Text] [Related]

  • 20. [Influencing of blood sugar, serum insulin level and nonesterified fatty acids during continuous feeding following orally administered sulfonylurea compounds ARDF 26 and glibenclamide].
    Zilker T, Waldthaler A, Lüders T, Ermler R, Bottermann P.
    Verh Dtsch Ges Inn Med; 1974 Dec 04; 80():1299-302. PubMed ID: 4217979
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.